[{"Assets_0_Q3_USD":10915900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":133500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":133800000.0,"StockholdersEquity_0_Q3_USD":5182400000.0,"RevenuesConverted_3_Q3_USD":3033800000.0,"RevenuesConverted_1_Q3_USD":1042700000.0,"NetIncomeLossConverted_3_Q3_USD":-78500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":133800000.0,"NetIncomeLossConverted_1_Q3_USD":-58900000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.59,"EarningsPerShareDiluted_1_Q3_USD":-0.44,"EarningsPerShareBasic_3_Q3_USD":-0.59,"EarningsPerShareBasic_1_Q3_USD":-0.44,"CommonStockSharesConverted_0_Q3_shares":133700000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.24,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":261700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":133500000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20211112"}]